[ET Net News Agency, 28 August 2025] HSBC raised the target price for Hansoh Pharma
(03692) to HKD47 from HKD45 and maintained the "buy" rating.
The research house said it raises net profit estimate by 4% in 2025e and cuts 2026-27e
estimates by 4-6%. (rc)